Haloperidol (Haldol)

ATI-format individual drug card with NCLEX-focused assessment, safety, teaching, and source attribution.

Back to meds
Mental HealthNeuroneeds review

Haloperidol (Haldol)

ATI class: Typical antipsychotic

Action

  • ATI/source-folder candidate for Haloperidol (Haldol); verify mechanism against the source table before validation.

Therapeutic use

  • Review under Antipsychotics medication safety.

Nursing assessment

  • Assess psychosis, agitation, safety risk, and response.
  • Monitor movement symptoms, rigidity, temperature, mental status, and autonomic instability.
  • Review QT risk and ECG monitoring when ordered.

Administration

  • Verify route against the order and source table.

Side effects

  • Verify common side effects against the source table.

Adverse effects

  • Extrapyramidal symptoms
  • Neuroleptic malignant syndrome
  • QT prolongation
  • Sedation
  • Tardive dyskinesia

Interactions

  • Other QT-prolonging drugs increase dysrhythmia risk.
  • CNS depressants increase sedation.
  • Anticholinergic or antiparkinson drugs may be used for EPS but add adverse-effect burden.

Contraindications

  • Hypersensitivity
  • Severe CNS depression or coma

Precautions

  • Use caution with Parkinson disease, Lewy body dementia, seizure disorder, QT risk, electrolyte abnormalities, and older adults with dementia-related psychosis.
  • Monitor for irreversible tardive dyskinesia with longer use.

Client teaching

  • Report fever, severe stiffness, confusion, abnormal movements, fainting, or palpitations.
  • Avoid alcohol and rise slowly.
  • Do not stop long-term therapy abruptly without provider guidance.

Medication outcomes

  • Therapeutic response with no priority adverse effects.

Antidote / rescue

  • No specific antidote is seeded; hold/question unsafe doses and manage toxicity per provider, facility, or poison-control guidance.

NCLEX priority cues

  • Fever plus rigidity plus autonomic instability suggests NMS.
  • Acute dystonia or severe EPS requires prompt review.
  • Tardive dyskinesia can be irreversible.

Medication classes

Antipsychotics

Source attribution

Google Drive source topic: Antipsychotics
google-drive
Sentinel pharmacology API reference
sentinel-api
Manual ATI-format NCLEX candidate normalization
manual-seed

Related study cards

Shows the medication class, ATI cues, source references, and connected study cards for this drug.

12 study links
Med classmedication class
Antipsychotics

Modulates dopamine and other neurotransmitters to reduce psychosis, agitation, or mania.

ATI cueNCLEX Priority Cue
Acute dystonia or severe EPS requires prompt review.

ATI medication nclex priority cue concept.

ATI cueInteraction
Anticholinergic or antiparkinson drugs may be used for EPS but add adverse-effect burden.

ATI medication interaction concept.

ATI cueNursing Assessment
Assess psychosis, agitation, safety risk, and response.

ATI medication nursing assessment concept.

ATI cueMechanism of Action
ATI/source-folder candidate for Haloperidol (Haldol); verify mechanism against the source table before validation.

ATI medication mechanism of action concept.

ATI cueClient Teaching
Avoid alcohol and rise slowly.

ATI medication client teaching concept.

ATI cueInteraction
CNS depressants increase sedation.

ATI medication interaction concept.

ATI cueClient Teaching
Do not stop long-term therapy abruptly without provider guidance.

ATI medication client teaching concept.

ATI cueAdverse Effect
Extrapyramidal symptoms

ATI medication adverse effect concept.

ATI cueNCLEX Priority Cue
Fever plus rigidity plus autonomic instability suggests NMS.

ATI medication nclex priority cue concept.

ATI cueContraindication
Hypersensitivity

ATI medication contraindication concept.

ATI cuePrecaution
Monitor for irreversible tardive dyskinesia with longer use.

ATI medication precaution concept.